TMCnet News

NantHealth Unveils Population Health Management Tools to Help Payers and Providers Deliver on Value-Based Care Initiatives
[March 31, 2021]

NantHealth Unveils Population Health Management Tools to Help Payers and Providers Deliver on Value-Based Care Initiatives


NantHealth, Inc. (NASDAQ: NH), today announced a new population health management product that pulls together disparate data to provide a full 360-degree picture of the patient while enabling better workflow between providers, payers, hospitals/healthcare networks and patients in one platform. This new product reduces avoidable costs and increases patient and provider satisfaction.

NantHealth is a provider of enterprise solutions that help businesses transform complex data into actionable insights and has added a population health management solution to meet critical needs of value-based care initiatives.

According to data from the American Hospital Association (AHA), 62% of payers and 43% of providers say they are participating in alternative payment models linked to quality. A population health management solution, like the one NantHealth is introducing, helps achieve that goal. It places the long-term needs of individual patients first, requiring historical healthcare data and advanced analytics to help physicians identify trends, deliver better care, and manage outcomes.

"Value-based care holds great opportunities in improving patient outcomes while mitigating unnecessary healthcare costs, yet there are still widespread challenges to its implementation," said Ron Louks, Chief Operating Officer at NantHealth. "The right tools and technologies can enable payers and providers to realize more efficient ways of working together and overcoming workflow challenges. The latest NantHealth population health management tools aim to solve this problem while removing some of the key barriers from legacy solutions that can stand in the way of evaluating data holistically to deliver the best patient care."

NantHealth's new population health management tools help payers and their providers unlock meaningful data at the point of care to:

  • Increase provider transparency
    The "at-a-glance" user interface helps payer and provider care management teams take advantage of and inject actionable insights into their existing workflow without having to juggle separate portals or screens. Increasing transparency means payers can reduce risk while better aligning with providers, making sure patients get the right care at the right time.
  • Streamline engagement
    Actively engaging patients and assigning care managers increases patient responsiveness and wellness resulting in happier providers and patients at lower costs.
  • Inform referrals
    By automating communications, including th transfer of health plan and patient clinical data and care information, primary care givers can refer the patient to the highest quality provider in the network and reduce network leakage.



NantHealth's population health management tools are available to all health plans including customers of Eviti Connect, a world-class evidence-based treatment intelligence platform that supports better decision making, and NaviNet Open, an industry-leading secure, multi-payer platform that elevates the payer-provider relationship from transactional to collaborative, enhancing communication and boosting operational efficiency. For more information visit, nanthealth.com/products/population-health-management.

About NantHealth, Inc.


NantHealth, a member of the NantWorks ecosystem of companies, provides enterprise solutions that help businesses transform complex data into actionable insights. By offering efficient ways to move, interpret, and visualize complex and highly sensitive information, NantHealth enables customers in healthcare, life sciences, logistics, telecommunications and other industries to automate, understand and act on data while keeping it secure and scalable. NantHealth's product portfolio comprises the latest technology in payer/provider collaboration platforms for real-time coverage decision support (Eviti and NaviNet), molecular analysis (GPS Cancer), and data solutions that provide multi-data analysis, reporting and professional services offerings (Quadris). OpenNMS, a NantHealth subsidiary, helps businesses monitor and manage network health and performance. For more information, visit nanthealth.com, follow us on Twitter, Facebook and LinkedIn, and subscribe to our blog.

Forward Looking Statement

This news release contains certain statements of a forward-looking nature relating to future events or future business performance. Forward-looking statements can be identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans," "will," "outlook" and similar expressions. Forward-looking statements are based on management's current plans, estimates, assumptions and projections, and speak only as of the date they are made. Risks and uncertainties include, but are not limited to: our ability to successfully integrate a complex learning system to address a wide range of healthcare issues; our ability to successfully amass the requisite data to achieve maximum network effects; appropriately allocating financial and human resources across a broad array of product and service offerings; raising additional capital as necessary to fund our operations; achieving significant commercial market acceptance for our sequencing and molecular analysis solutions; establish relationships with, key thought leaders or payers' key decision makers in order to establish GPS Cancer as a standard of care for patients with cancer; our ability to grow the market for our Systems Infrastructure, and applications; successfully enhancing our Systems Infrastructure and applications to achieve market acceptance and keep pace with technological developments; customer concentration; competition; security breaches; bandwidth limitations; our ability to integrate OpenNMS into our operations;; our ability to obtain regulatory approvals; dependence upon senior management; the need to comply with and meet applicable laws and regulations; unexpected adverse events; clinical adoption and market acceptance of GPS Cancer; and anticipated cost savings. We undertake no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our reports filed with the Securities and Exchange Commission.


[ Back To TMCnet.com's Homepage ]